News and Media : 2014 :

From left, Shivank Bhatia, M.D., Dipen Parekh, M.D., Bruce Kava, M.D., Christopher Gomez, M.D., and Sanoj Punnen, M.D.

Miller School Researchers to Study New Treatment for Benign Prostatic Hyperplasia

The Miller School of Medicine has been awarded a $470,000 grant to be part of a multicenter clinical trial to evaluate an emerging treatment option for benign prostatic hyperplasia (BPH), an enlarged prostate, which affects more than 50 percent of men over age 50. With this approval from the Food and Drug Administration, the University of Miami will be one of just ten sites in the nation and the second site in South Florida.

Read more »